Would gene therapy for the treatment of male infertility be safe?

Nature Clinical Practice Urology

Volumn 5, Issue 11, 2008, Pages 594-595

  Lamb, Dolores J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; OLIGONUCLEOTIDE; PARVOVIRUS VECTOR; RETROVIRUS VECTOR; RNA DIRECTED DNA POLYMERASE; SMALL INTERFERING RNA; VIRUS VECTOR;

ARTICLE; ARTIFICIAL CHROMOSOME; CLINICAL TRIAL; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DRUG SAFETY; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC DISORDER; GENETIC VARIABILITY; HEMOPHILIA B; HUMAN; IMMUNE RESPONSE; MALE INFERTILITY; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RESPIRATORY FAILURE; VIRAL GENE DELIVERY SYSTEM; X LINKED SEVERE COMBINED IMMUNODEFICIENCY; XENOTRANSPLANTATION;

ANIMALS; CONGENITAL ABNORMALITIES; GENE THERAPY; GENETIC VECTORS; HUMANS; INFERTILITY, MALE; MALE;

EID: 56349159974     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1238     Document Type: Article

References (16)

1. Somia N and Verma IM (2000) Gene therapy: Trials and tribulations. Nat Rev Genet 1: 91-99
2. van Drunen S and den Hurk LV (2006) Novel methods for the non-invasive administration of DNA therapeutics and vaccines. Curr Drug Deliv 3: 3-15
3. Daniel R and Smith JA (2008) Integration site selection by retroviral vectors: Molecular mechanism and clinical consequences. Hum Gene Ther 19: 557-568
4. Hacein-Bey-Abina S et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419
5. Manno CS et al. (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12: 342-347
6. Smith L and Byers JF (2002) Gene therapy in the post-Gelsinger era. JONAS Healthc Law Ethics Regul 4: 104-110
7. Gonin P and Gaillard C (2004) Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development. Gene Ther 11 (Suppl 1): S98-S108
8. Kazazian HH Jr (1999) An estimated frequency of endogenous insertional mutations in humans. Nat Genet 22: 130
9. Robaire B and Hales BF (2003) Mechanisms of action of cyclophosphamide as a male-mediated developmental toxicant. Adv Exp Med Biol 518 169-180
10. Kimmelman J (2008) The ethics of human gene transfer. Nat Rev Genet 9: 239-244
11. Brenner CA et al. (2000) Mitochondrial DNA heteroplasmy after human ooplasmic transplantation. Fertil Steril 74: 573-578
12. Barritt JA et al. (2001) Mitochondria in human offspring derived from ooplasmic transplantation. Hum Reprod 16: 513-516
13. Bergen JM et al. (2008) Nonviral approaches for neuronal delivery of nucleic acids. Pharm Res 25: 983-998
14. Li SD and Huang L (2006) Gene therapy progress and prospects: Non-viral gene therapy by systemic delivery. Gene Ther 13: 1313-1319
15. Sanvicens N and Marco MP (2008) Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol 26: 425-433
16. Louz D et al. (2005) Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines. J Gene Med 7: 1263-1274